China Roflumilast | 162401-32-3 supplier

Details for Roflumilast

Roflumilast

111Category:

Pharmaceuticals and Biochemicals

CAS NO:

162401-32-3

EC NO:

Molecular Formula:

C₁₇H₁₄Cl₂F₂N₂O₃

Molecular Weight:

403.2075

Specification:

InChI:

InChI=1/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)

Product description:
Product name:Roflumilast Chemical name:3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide CAS No.:162401-32-3 Specification:99.0%HPLC Molecular Formula:C17H14Cl2F2N2O3 Molecular Weight:403.21 Appearance: white powder Usage:On March 1,2011, the FDA approved the chronic obstructive pneumonia drug Daliresp (roflumilast), the drug used daily, can reduce asthma attack frequency or mitigate serious chronic obstructive pneumonia (COPD) symptoms.Roflumilast is a new category of COPD drug, phosphodiesterase - 4 (PDE - 4) inhibitors. Can be used among patients with serious COPD cough and bronchial symptom related much sputum, does not apply to mild emphysema.

Synonyms:

3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide;B 9302-107;BY 217;BYK 20869;Daxas;3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide;N-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide;

Molecular Structure:

if you are sourcing Roflumilast from China ,just feel free to inquire

Inquire